Broadlane, San Francisco, which offers group purchasing and other business services to the healthcare industry, acquired National Oncology Alliance, San Rafael, Calif., a GPO serving oncology physician practices. Financial terms were not disclosed. The U.S. pharmaceutical market for chemotherapy and related medications is about $10 billion annually, with office-based physician practices representing about $8 billion of the total purchases, officials said in a news release. For every office-based oncologist in the U.S., about $1.2 million is spent on such products annually. Founded in 2000, National Oncology serves more than 50% of the office-based oncology market, officials said. The acquisition was completed Wednesday. National Oncology now operates as a wholly owned subsidiary of Broadlane. Customers spend more than $7 billion annually through the two companies' contracts combined, the officials said. -- by Cinda Becker
Broadlane buys dominant GPO in oncology market
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.